Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation

por Palić, Semra, Bhairosing, Patrick, Beijnen, Jos H., Dorlo, Thomas P. C.
Publicado 2019

Access to the CNS: Biomarker Strategies for Dopaminergic Treatments

por van den Brink, Willem Johan, Palic, Semra, Köhler, Isabelle, de Lange, Elizabeth Cunera Maria
Publicado 2018

Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa

por Palić, Semra, Kip, Anke E, Beijnen, Jos H, Mbui, Jane, Musa, Ahmed, Solomos, Alexandra, Wasunna, Monique, Olobo, Joseph, Alves, Fabiana, Dorlo, Thomas P C
Publicado 2020

Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach

por Brussee, Janneke M., Yu, Huixin, Krekels, Elke H. J., Palić, Semra, Brill, Margreke J. E., Barrett, Jeffrey S., Rostami-Hodjegan, Amin, de Wildt, Saskia N., Knibbe, Catherijne A. J.
Publicado 2018

A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children

por Brussee, Janneke M., Krekels, Elke H. J., Calvier, Elisa A. M., Palić, Semra, Rostami-Hodjegan, Amin, Danhof, Meindert, Barrett, Jeffrey S., de Wildt, Saskia N., Knibbe, Catherijne A. J.
Publicado 2019